Iva Healthcare posts 35% growth in terms of sales
Iva Healthcare proudly declared 35% profits growth and got new approvals for Teneligliptin 20mg and Metformin Hydrochloride 500mg {SR}. Iva gave credits of success to their new marketing strategy, competent…
ED opposes bail plea of accused in bank loan fraud case of over Rs 5K cr
New Delhi: ED opposes bail plea of accused in bank loan fraud case of over Rs 5K cr A Delhi court Thursday reserved for tomorrow its order on the bail…
Saridon, Panderm among over 6,000 medicines face ban
New Delhi: The Centre’s decision on Wednesday to ban the manufacture, sale and distribution of 328 Fixed Dose Combination (FDC) drugs has brought around 6,000 prominent medicines under the radar,…
FDA approves AstraZeneca’s drug for rare form of blood cancer
The U.S. Food and Drug Administration said on Thursday it approved AstraZeneca Plc’s treatment for hairy cell leukemia, a slow-growing type of blood cancer. The treatment, marketed as Lumoxiti, was…
Banning 328 FDCs a step towards rectifying ‘grave’ situation of pharma market: AIDAN
New Delhi: Lauding the government’s decision to ban 328 fixed-dose combination (FDC) of drugs and restricting another six, a group of NGOs Thursday said it was a step towards rectifying…
How clerk-turned-billionaire Ramprasad Reddy made Aurobindo a giant pharma company
We don’t know if Ramprasad Reddy’s proudest moment was the invitation by then Secretary General Kofi Annan to speak at the United Nations in November 2006 – he is one…
Sun Pharma shares spurt 3 pc; m-cap rises by Rs 4,500 cr
New Delhi: Shares of Sun Pharma Wednesday witnessed volatile trading but finally settled with gains of nearly 3 per cent, following which the market capitalisation of the company rose by…
Government prohibits 328 fixed dose combinations
The health ministry pruned a list of banned combination medicines and added restrictions to the dosages or uses for six more types of such drugs, saying their ingredients had no…
U.S. appeals court invalidates Acorda patents on MS drug
By Jan Wolfe A U.S. appeals court on Monday invalidated Acorda Therapeutics Inc patents covering its multiple sclerosis drug Ampyra, opening the door for generic competition for Acorda’s flagship product.…
Orexo soars after winning opioid drug appeal against Teva
By Jonathan Stempel A U.S. appeals court on Monday revived Swedish pharmaceutical company Orexo AB’s lawsuit accusing a unit of Israel’s Teva Pharmaceutical Industries Ltd of infringing a patent for…
